NEUROIMMUNOLOGY OF HUMAN NEUROTROPIC JCV DNA REPLICATION

Information

  • Research Project
  • 2890841
  • ApplicationId
    2890841
  • Core Project Number
    R01MH056105
  • Full Project Number
    5R01MH056105-04
  • Serial Number
    56105
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/5/1997 - 27 years ago
  • Project End Date
    8/31/1999 - 24 years ago
  • Program Officer Name
    WINSKY, LOIS M.
  • Budget Start Date
    5/1/1999 - 25 years ago
  • Budget End Date
    8/31/1999 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    4
  • Suffix
  • Award Notice Date
    4/11/2002 - 22 years ago
Organizations

NEUROIMMUNOLOGY OF HUMAN NEUROTROPIC JCV DNA REPLICATION

DESCRIPTION (Adapted from applicant's abstract): Coordination of the immune response to viral infection and disease in the brain is believed to involve bi-directional discourse between the immune system and the central nervous system (CNS). Progressive multifocal leukoencephalopathy (PML) is a neurodegenerative disease associated with a wide range of neurological impairments and neurobehavioral dysfunction including subcortical dementia. The human polyomavirus, JCV, which infects greater than 70% of the adult population, is the etiological agent of this disease. Infection with JCV occurs during childhood and the virus remains at the latent state with no apparent clinical symptoms. However, under immunosuppressed conditions, the virus enters the lytic cycle, and upon cytolytic destruction of glial cells, causes PML. The investigators hypothesize that the bi-modal interaction of immune and nervous systems promotes a regulatory mechanism in the JCV-infected cells which suppresses viral replication and maintains the virus in the latent state. Thus, the absence of this negative regulator in the infected cells leads to the reactivation of JCV and the development of PML. In support of this hypothesis the investigators have demonstrated that secretory factor from immune cells derived from non-PML individuals and that stimulate expression of a cellular protein in glial cells which binds to the viral origin of DNA replication, inhibit JCV DNA replication in glial cells. In this research project, the investigators propose to: (i) determine the immune cell induced negative regulatory factors from glial cells which are responsible for suppression of JCV replication, (ii) evaluate the ability of immune cells from PML patients in suppressing JCV DNA replication and inducing the activity of the candidate suppressor protein; and (iii) molecularly clone the gene encoding the suppressor protein and assess its expression and function in PML and non-PML individuals.

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    R01
  • Administering IC
    MH
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    242
  • Ed Inst. Type
    OVERALL MEDICAL
  • Funding ICs
  • Funding Mechanism
  • Study Section
    MHAI
  • Study Section Name
    Mental Health AIDS and Immunology Review Committee
  • Organization Name
    MCP HAHNEMANN UNIVERSITY
  • Organization Department
    NONE
  • Organization DUNS
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191021192
  • Organization District
    UNITED STATES